Cetuximab

Common card · No. 399616

Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion. Cetuximab was approved for medical use in the United States in 2004.

Read on Wikipedia · Image Oguenther at German Wikipedia, Public domain